Takeda Pharmaceutical Net Debt Growth & History (TAK)

Takeda Pharmaceutical's net debt was ¥4.29T for fiscal 2026.

View full Takeda Pharmaceutical company overview

Takeda Pharmaceutical annual net debt history

Takeda Pharmaceutical annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20262026-03-31¥4.29T−¥416.69B−8.86%
20252025-03-31¥4.70T−¥302.11B−6.04%
20242024-03-31¥5.01T¥677.43B+15.65%
20232023-03-31¥4.33T¥367.21B+9.27%
20222022-03-31¥3.96T−¥144.61B−3.52%
20212021-03-31¥4.11T−¥719.59B−14.91%
20202020-03-31¥4.83T−¥223.71B−4.43%
20192019-03-31¥5.05T¥4.36T+630.51%
20182018-03-31¥691.14B

Takeda Pharmaceutical net debt trends

Over the last five fiscal years, Takeda Pharmaceutical's net debt increased from ¥4.11T to ¥4.29T, a change of ¥181.22B. The latest reported quarter, Q1 2027, shows ¥4.48T.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Takeda Pharmaceutical source filings ↗

Community posts

It’s quiet here.

No posts about TAK yet. Start the conversation.

Write the first post